Please login to create your UC TechAlerts.
Request a new password for
Required
FIP (Feline Infectious Peritonitis) mRNA Vaccine
Researchers at the University of California, Davis have developed an approach to combat Feline Infectious Peritonitis (FIP) through an in vitro-transcribed (IVT) RNA vaccine targeting the FCoV nucleocapsid (N) protein antigen.
Monoclonal Antibodies Specific For Canine C-Kit
Please view this family of technologies HERE
Monoclonal Antibodies: CCR4 Antibody for Treating Canine Lymphoma and c-KIT Monoclonal Antibodies for Detecting and Treating Canine Mast Cell Tumors
Researchers at the University of California, Davis, have developed a monoclonal antibody for treating and diagnosing T cell lymphoma in dogs as well as monoclonal antibodies targeting c-KIT for treating and diagnosing mast cell tumors in dogs.
Monoclonal Neutralizing Antibodies Specific for Canine TNF Alpha
Researchers at the University of California, Davis have developed monoclonal antibodies engineered for the treatment and detection of autoimmune disorders and cancers in dogs.
JC071ch, a Chimeric Monoclonal Antibody Specific for Canine PDL1
JC071c4, a Caninized Monoclonal Antibody Mutant Specific for Canine PDL1 That Could Avoid Potential Nglycosylation within Light Chain CDR1
JC071c2, a Caninized Monoclonal Antibody Mutant Specific for Canine PDL1 That Could Avoid Potential Nglycosylation and W Oxidation
JC071c1, a Caninized Monoclonal Antibody Mutant Specific for Canine PDL1 That Could Avoid Potential Nglycosylation and N-deamidation within CDR Sequences
Jc071c, a Caninized Monoclonal Antibody Specific for Canine Pd-L1
Researchers at the University of California, Davis, have developed a modified, caninized monoclonal antibody that targets canine PD-L1, developed for use as dog cancer therapy.
Biologic Fish Skin Bandage for Healing Burns and Other Wounds
Researchers at the University of California, Davis have developed a biologic dressing derived from fish skin to enhance wound healing.
Temporomandibular Joint Replacement (Tmjr) Prosthesis For Dogs And Cats
Researchers at the University of California, Davis, have developed a 3D-printed implant for dogs and cats for treating TMJ ankylosis. The device can accommodate any sized animal and is produced with biocompatible materials with high stress/strain resistance.
Anti-microbial, Immune-modulating, Naturally-derived Adjunctive Therapies
Researchers at the University of California, Davis have developed adjunctive therapies applicable to multiple types of infectious conditions. These therapies – derived from compounds found in natural herbs - also have potential prophylactic efficacy.
Non-Antibiotic, Treatment for Recurrent UTIs in Canines
Researchers at the University of California, Davis have developed a biologic treatment for mitigating pain and treating acute urinary tract infections (UTIs) in canines.
Monoclonal Antibodies Specific to Canine PD-1 and PD-L1
Researchers at the University of California, Davis have developed monoclonal antibodies with multiple applications relevant to canine PD-1 and PD-L1.
Machine Learning Program that Diagnoses Hypoadrenocorticism in Dogs Using Standard Blood Test Results
Researchers at the University of California, Davis have developed a program based on machine learning algorithms to aid in diagnosing hypoadrenocorticism.
Applying a Machine Learning Algorithm to Canine Radiographs for Automated Detection of Left Atrial Enlargement
Researchers at the University of California, Davis have developed a method of detecting canine left atrial enlargement as an early sign of mitral valve disease by applying machine learning techniques to thoracic radiograph images.
Diagnostic Marker for Chondrodystrophy and Intervertebral Disk Disease Susceptibility in Canines
Researchers at the University of California, Davis, have developed a diagnostic method to identify dogs that are at risk for chondrodystrophy and/or intervertebral disc disease.
A New Pharmaceutical Therapy Target for Depression and Other Central Nervous System Diseases
Researchers at the University of California, Davis have discovered a new signal pathway involved in depression. This could be a potential target of pharmacological treatment of central nervous system disease and specially depression in man and companion animals. The technology could be best practiced with soluble epoxide hydrolase inhibitors, which have high oral bioavailability, good pharmacokinetics, picomolar potency, low toxicity and CNS activity.
Novel Imaging Technique Combines Optical and MR Imaging Systems To Obtain High Resolution Optical Images
Researchers at the University of California, Irvine have developed a novel high resolution imaging technique, referred to as Photo-Magnetic Imaging (PMI), that combines the abilities of optical and magnetic resonance (MR) imaging systems. Images are created with PMI by heating tissue with a light (e.g. laser) and measuring the resulting temperature change with MR Thermometry. This change in temperature can then be related to a tissue’s absorption, scattering, and metabolic properties. PMI addresses the limitations of current optical imaging techniques by providing a repeatable, non-contact, high resolution optical image with increased quantitative accuracy. This technique can be used for a wide-range of applications including but not limited to imaging of small animals for research purposes. This technique may also be used in imaging the tissue and organs of a patient.